The estimated Net Worth of Kenneth C Frazier is at least $158 Million dollars as of 7 November 2022. Mr. Frazier owns over 235,769 units of Merck & Co Inc stock worth over $107,416,968 and over the last 15 years he sold MRK stock worth over $22,797,600. In addition, he makes $27,648,500 as Chairman of the Board, President, and Chief Executive Officer at Merck & Co Inc.
Kenneth has made over 39 trades of the Merck & Co Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 235,769 units of MRK stock worth $27,045,062 on 7 November 2022.
The largest trade he's ever made was exercising 867,084 units of Merck & Co Inc stock on 28 October 2022 worth over $99,463,206. On average, Kenneth trades about 72,960 units every 55 days since 2009. As of 7 November 2022 he still owns at least 936,422 units of Merck & Co Inc stock.
You can see the complete history of Mr. Frazier stock trades at the bottom of the page.
Kenneth C. Frazier is Chairman of the Board, President and Chief Executive Officer of the Company. Mr. Frazier has broad managerial and operational expertise and deep institutional knowledge, as well as a track record of achievement, integrity and sound judgment demonstrated prior to, and during, his long tenure with Merck. In addition, his role as the Chair of the Board Affairs Committee of Exxon Mobil Corporation has provided him with important experience on governance issues facing public companies. ?Chairman and Chief Executive Officer (2011-present) ?President (2010-present), ?Executive Vice President and President, Global Human Health (2007-2010), Executive Vice President and General Counsel (2006-2007), Senior Vice President and General Counsel (1999-2006). Exxon Mobil Corporation (since 2009).
As the Chairman of the Board, President, and Chief Executive Officer of Merck & Co Inc, the total compensation of Kenneth Frazier at Merck & Co Inc is $27,648,500. There are no executives at Merck & Co Inc getting paid more.
Kenneth Frazier is 65, he's been the Chairman of the Board, President, and Chief Executive Officer of Merck & Co Inc since 2011. There are 8 older and 19 younger executives at Merck & Co Inc. The oldest executive at Merck & Co Inc is Thomas Cech, 73, who is the Independent Director.
Kenneth's mailing address filed with the SEC is MERCK & CO., INC., 126 E. LINCOLN AVENUE, RAHWAY, NJ, 07065.
Over the last 15 years, insiders at Merck & Co Inc have traded over $138,980,380 worth of Merck & Co Inc stock and bought 48,209 units worth $1,563,736 . The most active insiders traders include Wendell P Weeks, Kenneth C Frazier, and Douglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of $5,050,222. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth $4,250,995.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Merck & Co Inc executives and other stock owners filed with the SEC include: